Raymond Goodrich Terumo BCT Scientific Affairs Biography Publications Institution JoVE Articles Raymond Goodrich has not added a biography. If you are Raymond Goodrich and would like to personalize this page please email our Author Liaison for assistance. Publications Inactivation of Viruses in Platelet and Plasma Products Using a Riboflavin-and-UV-based Photochemical Treatment Transfusion. Jul, 2015 | Pubmed ID: 25731607 Large Animal Evaluation of Riboflavin and Ultraviolet Light-treated Whole Blood Transfusion in a Diffuse, Nonsurgical Bleeding Porcine Model Transfusion. Mar, 2015 | Pubmed ID: 25582335 Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage Shock (Augusta, Ga.). Aug, 2015 | Pubmed ID: 25423125 Reduction of Leishmania Donovani Infectivity in Whole Blood Using Riboflavin and Ultraviolet Light Transfusion. Feb, 2015 | Pubmed ID: 25156473 The Effect of Riboflavin and Ultraviolet Light on the Infectivity of Arboviruses Transfusion. Nov, 2014 | Pubmed ID: 25370822 Whole Blood Treated with Riboflavin and Ultraviolet Light: Quality Assessment of All Blood Components Produced by the Buffy Coat Method Transfusion. Oct, 2014 | Pubmed ID: 25355434 Chemical and Biological Mechanisms of Pathogen Reduction Technologies Photochemistry and Photobiology. Sep-Oct, 2014 | Pubmed ID: 25041351 Plasma Constituent Integrity in Pre-storage Vs. Post-storage Riboflavin and UV-light Treatment--a Comparative Study Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis. Dec, 2013 | Pubmed ID: 23820430 Riboflavin and Ultraviolet Light Treatment of Platelets Triggers P38MAPK Signaling: Inhibition Significantly Improves in Vitro Platelet Quality After Pathogen Reduction Treatment Transfusion. Dec, 2013 | Pubmed ID: 23521225 Immune Modulation and Lack of Alloimmunization Following Transfusion with Pathogen-reduced Platelets in Mice Transfusion. Mar, 2013 | Pubmed ID: 23451715 Inactivation of Plasmodium Spp. in Plasma and Platelet Concentrates Using Riboflavin and Ultraviolet Light Transfusion. Oct, 2013 | Pubmed ID: 23320495 Primary Hemostatic Capacity of Whole Blood: a Comprehensive Analysis of Pathogen Reduction and Refrigeration Effects over Time Transfusion. Jan, 2013 | Pubmed ID: 23301966 Development of a Riboflavin and Ultraviolet Light-based Device to Treat Whole Blood Transfusion. Jan, 2013 | Pubmed ID: 23301965 A Pilot Study to Assess the Hemostatic Function of Pathogen-reduced Platelets in Patients with Thrombocytopenia Transfusion. Sep, 2013 | Pubmed ID: 23278371 Riboflavin and Ultraviolet Light Reduce the Infectivity of Babesia Microti in Whole Blood Transfusion. Apr, 2013 | Pubmed ID: 22803831 Photochemical Inactivation of Chikungunya Virus in Plasma and Platelets Using the Mirasol Pathogen Reduction Technology System Transfusion. Feb, 2013 | Pubmed ID: 22626525 In Reply To: "Is the SCID Mouse Model Applicable to Human Acute Lung Injury?" Transfusion. Nov, 2012 | Pubmed ID: 23140431 The Utility of Pathogen Inactivation Technology: a Real-life Example of Leishmania Infantum Inactivation in Platelets from a Donor with an Asymptomatic Infection Blood Transfusion = Trasfusione Del Sangue. Oct, 2012 | Pubmed ID: 22790276 Fresh Whole Blood Use for Hemorrhagic Shock: Preserving Benefit While Avoiding Complications Anesthesia and Analgesia. Oct, 2012 | Pubmed ID: 22763908 Preparation of Cryoprecipitate from Riboflavin and UV Light-treated Plasma Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis. Apr, 2012 | Pubmed ID: 22342281 Quality of Proteins in Riboflavin and UV Light-treated FFP During 1 Year of Storage at -18°C Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis. Feb, 2012 | Pubmed ID: 22115607 Evaluating Pathogen Reduction of Trypanosoma Cruzi with Riboflavin and Ultraviolet Light for Whole Blood Transfusion. Feb, 2012 | Pubmed ID: 21827502 Improving Blood Safety and Patient Outcomes with Pathogen Reduction Technology Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis. Dec, 2011 | Pubmed ID: 22078570 Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie. 2011 | Pubmed ID: 21779202 FDA Workshop on Emerging Infectious Diseases: Evaluating Emerging Infectious Diseases (EIDs) for Transfusion Safety Transfusion. Aug, 2011 | Pubmed ID: 21392016 In Vivo Viability of Stored Red Blood Cells Derived from Riboflavin Plus Ultraviolet Light-treated Whole Blood Transfusion. Jul, 2011 | Pubmed ID: 21275998 Protein Stability of Previously Frozen Plasma, Riboflavin and UV Light-treated, Refrozen and Stored for Up to 2 Years at -30 °C Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis. Feb, 2011 | Pubmed ID: 21251884 Generation of Neutrophil Priming Activity by Cell-containing Blood Components Treated with Pathogen Reduction Technology and Stored in Platelet Additive Solutions Transfusion. Jun, 2011 | Pubmed ID: 21155831 Impact of Pathogen Reduction Technology and Storage in Platelet Additive Solutions on Platelet Function Transfusion. Apr, 2011 | Pubmed ID: 20977485 Hemostatic Function of Buffy Coat Platelets in Additive Solution Treated with Pathogen Reduction Technology Transfusion. Feb, 2011 | Pubmed ID: 20723169 White Blood Cell Inactivation After Treatment with Riboflavin and Ultraviolet Light Transfusion. Nov, 2010 | Pubmed ID: 20529002 In Vitro Cell Quality of Buffy Coat Platelets in Additive Solution Treated with Pathogen Reduction Technology Transfusion. Oct, 2010 | Pubmed ID: 20456708 Defining "adequate" Pathogen Reduction Performance for Transfused Blood Components Transfusion. Aug, 2010 | Pubmed ID: 20374558 Design and Development of a Method for the Reduction of Infectious Pathogen Load and Inactivation of White Blood Cells in Whole Blood Products Biologicals : Journal of the International Association of Biological Standardization. Jan, 2010 | Pubmed ID: 20093041 Evaluation of the Mirasol Pathogen [corrected] Reduction Technology System Against Babesia Microti in Apheresis Platelets and Plasma Transfusion. May, 2010 | Pubmed ID: 20030791 Lack of Antibody Formation to Platelet Neoantigens After Transfusion of Riboflavin and Ultraviolet Light-treated Platelet Concentrates Transfusion. Dec, 2009 | Pubmed ID: 19694996 Understanding Loss of Donor White Blood Cell Immunogenicity After Pathogen Reduction: Mechanisms of Action in Ultraviolet Illumination and Riboflavin Treatment Transfusion. Dec, 2009 | Pubmed ID: 19682337 A Laboratory Comparison of Pathogen Reduction Technology Treatment and Culture of Platelet Products for Addressing Bacterial Contamination Concerns Transfusion. Jun, 2009 | Pubmed ID: 19320867 Evaluation of Potential Immune Response and in Vivo Survival of Riboflavin-ultraviolet Light-treated Red Blood Cells in Baboons Transfusion. Jan, 2009 | Pubmed ID: 18954398 Reduction of Prion Infectivity in Packed Red Blood Cells Biochemical and Biophysical Research Communications. Dec, 2008 | Pubmed ID: 18851948 Toxicity Testing of a Novel Riboflavin-based Technology for Pathogen Reduction and White Blood Cell Inactivation Transfusion Medicine Reviews. Apr, 2008 | Pubmed ID: 18353253 Treatment with Riboflavin and Ultraviolet Light Prevents Alloimmunization to Platelet Transfusions and Cardiac Transplants Transplantation. Nov, 2007 | Pubmed ID: 17998874 Pathogen Inactivation of Trypanosoma Cruzi in Plasma and Platelet Concentrates Using Riboflavin and Ultraviolet Light Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis. Oct, 2007 | Pubmed ID: 17950672 Inactivation of Orientia Tsutsugamushi in Red Blood Cells, Plasma, and Platelets with Riboflavin and Light, As Demonstrated in an Animal Model Transfusion. Feb, 2007 | Pubmed ID: 17302769 Mirasol PRT Treatment of Donor White Blood Cells Prevents the Development of Xenogeneic Graft-versus-host Disease in Rag2-/-gamma C-/- Double Knockout Mice Transfusion. Sep, 2006 | Pubmed ID: 16965583 The Mirasol PRT System for Pathogen Reduction of Platelets and Plasma: an Overview of Current Status and Future Trends Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis. Aug, 2006 | Pubmed ID: 16935562 Correlation of in Vitro Platelet Quality Measurements with in Vivo Platelet Viability in Human Subjects Vox Sanguinis. May, 2006 | Pubmed ID: 16635070 Functional Inactivation of White Blood Cells by Mirasol Treatment Transfusion. Apr, 2006 | Pubmed ID: 16584442 Platelet Glycolytic Flux Increases Stimulated by Ultraviolet-induced Stress is Not the Direct Cause of Platelet Morphology and Activation Changes: Possible Implications for the Role of Glucose in Platelet Storage Transfusion. Nov, 2005 | Pubmed ID: 16271100 Efficacy of Apheresis Platelets Treated with Riboflavin and Ultraviolet Light for Pathogen Reduction Transfusion. Aug, 2005 | Pubmed ID: 16078923 Comparison of Computerized Formulae for Determination of Platelet Recovery and Survival Transfusion. Jul, 2005 | Pubmed ID: 15987377 Evaluation of Platelet Mitochondria Integrity After Treatment with Mirasol Pathogen Reduction Technology Transfusion. Jun, 2005 | Pubmed ID: 15934990 An Action Spectrum of the Riboflavin-photosensitized Inactivation of Lambda Phage Photochemistry and Photobiology. Mar-Apr, 2005 | Pubmed ID: 15623353 Separation, Identification and Quantification of Riboflavin and Its Photoproducts in Blood Products Using High-performance Liquid Chromatography with Fluorescence Detection: a Method to Support Pathogen Reduction Technology Photochemistry and Photobiology. Nov-Dec, 2004 | Pubmed ID: 15382964 Riboflavin and UV-light Based Pathogen Reduction: Extent and Consequence of DNA Damage at the Molecular Level Photochemistry and Photobiology. Jul-Aug, 2004 | Pubmed ID: 15339215 Photochemical Inactivation of Selected Viruses and Bacteria in Platelet Concentrates Using Riboflavin and Light Transfusion. Jun, 2004 | Pubmed ID: 15157255 Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination Shawn D. Keil1, Nick Hovenga1, Denise Gilmour1, Susanne Marschner1, Raymond Goodrich1 1Terumo BCT, Scientific Affairs JoVE 52820 Immunology and Infection
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination Shawn D. Keil1, Nick Hovenga1, Denise Gilmour1, Susanne Marschner1, Raymond Goodrich1 1Terumo BCT, Scientific Affairs JoVE 52820 Immunology and Infection
